India neomycin market is expected to grow at a formidable rate during the forecast period. Neomycin is an antibiotic which is effective against both gram-positive and gram-negative bacteria. The India neomycin market is driven by use of this drug in combination with polymyxin B sulfate and dexamethasone in ophthalmic preparations for treating infections in the eye. Moreover, neomycin is widely used to treat skin and structures infections which is forecasted to positively influence the market growth. Growing innovations and new product launches is further expected to boost the growth of India neomycin market through FY2026.

The India neomycin market is segmented based on form, source, route of administration, type of composition, distribution channel, application, end user, company, and region. Based on application, the market can be segmented into ear infection, skin infection, ocular infection and others. Among these, ocular infection segment is expected to witness high growth in the market over the coming years on account of utilization of ophthalmic solution containing neomycin in combination with polymyxin B sulfates and dexamethasone for treating steroid-responsive inflammatory ocular conditions.

The major players operating in the India neomycin market are Taj Pharmaceuticals Ltd., Salvavidas Pharmaceutical Pvt. Ltd., Lexicare Pharma Pvt. Ltd., Facemed Pharmaceuticals Pvt. Ltd., Unichem Laboratories Ltd., Gujarat Pharma Lab Pvt. Ltd., Dupen Lab Pvt. Ltd., Caldern Pharmaceuticals Ltd., Sunways India Pvt. Ltd., Allergan India Pvt. Ltd., and others. Major companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, research collaborations and new product developments to expand their geographic reach and to increase their customer basis.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India neomycin market from FY2016 to FY2019.
  • To estimate and forecast the market size of India neomycin market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India neomycin market based on form, source, route of administration, type of composition, distribution channel, application, end user, company, and regional distribution.
  • To identify dominant region or segment in the India neomycin market.
  • To identify drivers and challenges for India neomycin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India neomycin market.
  • To identify and analyze the profile of leading players operating in India neomycin market.
  • To identify key sustainable strategies adopted by market players in India neomycin market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India neomycin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Neomycin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to neomycin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India neomycin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Neomycin Market, By Form:
    • Tablet
    • Eye and Ear Drops
    • Ointment
    • Syrup
    • Injection
  • India Neomycin Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Neomycin Market, By Route of Administration:
    • Oral
    • Ophthalmic
    • Otic
    • Topical
    • Intravenous
  • India Neomycin Market, By Type of Composition:

o   Neomycin sulphate

o   Neomycin palmitate

  • India Neomycin Market, By Distribution Channel:
    • Online
    • Offline
  • India Neomycin Market, By Application:
    • Ear Infection
    • Skin Infection
    • Ocular Infection
    • Others
  • India Neomycin Market, By End User:
    • Adult
    • Paediatric
  • India Neomycin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India neomycin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India neomycin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Neomycin Market

4.    Executive Summary

5.    Manufacturing Neomycin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Neomycin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Neomycin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Form (Tablet, Eye and Ear Drops, Ointment, Syrup and Injection)

7.2.2.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.3.     By Route of Administration (Oral, Ophthalmic, Otic, Topical and Intravenous)

7.2.4.     By Type of Composition (Neomycin sulphate v/s neomycin palmitate)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Application (Ear Infection, Skin Infection, Ocular Infection and Others)

7.2.7.     By End User (Adult v/s Paediatric)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Taj Pharmaceuticals Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Salvavidas Pharmaceutical Pvt. Ltd.

14.1.3.  Lexicare Pharma Pvt. Ltd.

14.1.4.  Facemed Pharmaceuticals Pvt. Ltd.

14.1.5.  Unichem Laboratories Ltd.

14.1.6.  Gujarat Pharma Lab Pvt. Ltd.

14.1.7.  Dupen Lab Pvt. Ltd.

14.1.8.  Caldern Pharmaceuticals Ltd.

14.1.9.  Sunways India Pvt. Ltd.

14.1.10.                Allergan India Pvt. Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer 

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com